Literature DB >> 23558134

Clusters of genetically similar isolates of Pseudomonas aeruginosa from multiple hospitals in the UK.

Kate Martin1, Buket Baddal1, Nazim Mustafa1, Claire Perry1, Anthony Underwood2, Chrystala Constantidou3, Nick Loman3, Dervla T Kenna1, Jane F Turton1.   

Abstract

Variable number tandem repeat (VNTR) analysis at nine loci of isolates of Pseudomonas aeruginosa submitted to the national reference laboratory from UK hospitals, from over 2000 patients, between June 2010 and June 2012 revealed four widely found types that collectively were received from approximately a fifth of patients, including from those with cystic fibrosis. These types were also prevalent among related submissions from the clinical environment and were received from up to 54 (out of 143) hospitals. Multi-locus sequence typing and blaOXA-50-like sequencing confirmed the clonal relationship within each cluster, and representatives from multiple centres clustered within about 70 % by pulsed-field gel electrophoresis. Illumina sequencing of 12 isolates of cluster A of VNTR profile 8, 3, 4, 5, 2, 3, 5, 2, x (where the repeat number at the last, most discriminatory locus is variable) revealed a large number of variably present targets in the accessory genome and seven of these were sought by PCR among a larger set of isolates. Representatives from patients within a single centre mostly had distinct accessory gene profiles, suggesting that these patients acquired the strain independently, while those with clear epidemiological links shared the same profile. Profiles also varied between representatives from different centres. Epidemiological investigations of widely found types such as these require the use of finer-typing methods, which increasingly will be informed by next generation sequencing.

Entities:  

Mesh:

Year:  2013        PMID: 23558134     DOI: 10.1099/jmm.0.054841-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  19 in total

1.  High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United Kingdom.

Authors:  Jane F Turton; Laura Wright; Anthony Underwood; Adam A Witney; Yuen-Ting Chan; Ali Al-Shahib; Catherine Arnold; Michel Doumith; Bharat Patel; Timothy D Planche; Jonathan Green; Richard Holliman; Neil Woodford
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

Review 2.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

3.  Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections.

Authors:  David Williams; Benjamin Evans; Sam Haldenby; Martin J Walshaw; Michael A Brockhurst; Craig Winstanley; Steve Paterson
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

4.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

5.  Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.

Authors:  Luca Freschi; Julie Jeukens; Irena Kukavica-Ibrulj; Brian Boyle; Marie-Josée Dupont; Jérôme Laroche; Stéphane Larose; Halim Maaroufi; Joanne L Fothergill; Matthew Moore; Geoffrey L Winsor; Shawn D Aaron; Jean Barbeau; Scott C Bell; Jane L Burns; Miguel Camara; André Cantin; Steve J Charette; Ken Dewar; Éric Déziel; Keith Grimwood; Robert E W Hancock; Joe J Harrison; Stephan Heeb; Lars Jelsbak; Baofeng Jia; Dervla T Kenna; Timothy J Kidd; Jens Klockgether; Joseph S Lam; Iain L Lamont; Shawn Lewenza; Nick Loman; François Malouin; Jim Manos; Andrew G McArthur; Josie McKeown; Julie Milot; Hardeep Naghra; Dao Nguyen; Sheldon K Pereira; Gabriel G Perron; Jean-Paul Pirnay; Paul B Rainey; Simon Rousseau; Pedro M Santos; Anne Stephenson; Véronique Taylor; Jane F Turton; Nicholas Waglechner; Paul Williams; Sandra W Thrane; Gerard D Wright; Fiona S L Brinkman; Nicholas P Tucker; Burkhard Tümmler; Craig Winstanley; Roger C Levesque
Journal:  Front Microbiol       Date:  2015-09-29       Impact factor: 5.640

6.  Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.

Authors:  Chloe E James; Emily V Davies; Joanne L Fothergill; Martin J Walshaw; Colin M Beale; Michael A Brockhurst; Craig Winstanley
Journal:  ISME J       Date:  2014-12-02       Impact factor: 10.302

7.  Seeking the source of Pseudomonas aeruginosa infections in a recently opened hospital: an observational study using whole-genome sequencing.

Authors:  Joshua Quick; Nicola Cumley; Christopher M Wearn; Marc Niebel; Chrystala Constantinidou; Chris M Thomas; Mark J Pallen; Naiem S Moiemen; Amy Bamford; Beryl Oppenheim; Nicholas J Loman
Journal:  BMJ Open       Date:  2014-11-04       Impact factor: 2.692

8.  Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.

Authors:  Emily V Davies; Chloe E James; Michael A Brockhurst; Craig Winstanley
Journal:  BMC Microbiol       Date:  2017-01-05       Impact factor: 3.605

9.  Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395.

Authors:  Marie Petitjean; Daniel Martak; Alicia Silvant; Xavier Bertrand; Benoit Valot; Didier Hocquet
Journal:  Microb Genom       Date:  2017-06-08

10.  Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.

Authors:  R Somayaji; B Waddell; M L Workentine; M G Surette; N P Brager; H R Rabin; M D Parkins
Journal:  BMC Pulm Med       Date:  2015-11-05       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.